Charles Stark
Vermogen: 182 $ op 31-05-2026
Vermogen: 182 $ op 31-05-2026
Dr. Charles W.
Stark is a Senior Vice President-Medical Affairs at EMI Holding, Inc. and a Chief Science Officer & EVP-Clinical Development at Emmaus Life Sciences, Inc. He is on the Board of Directors at St. Mary's Regional Medical Center (Oklahoma).
Dr. Stark was previously employed as a Director-Clinical Development by Bavarian Nordic A/S, an Associate Director-Medical Affairs by Dendreon Corp., a Director-Investigational Drug Services by Harbor-UCLA Medical Center, a Director-Investigational Drug Services by Health Research Association, Inc., a Director-Investigational Drug Services by Los Angeles Biomedical Research Institute at Harbor-UCLA, a Director-Investigational Drug Services by Los Angeles County+USC Medical Center, and a Director-Medical Science Liaisons by Pfizer Inc. He received his doctorate degree from the University of Southern California.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2025 | 18.182 ( 0,03% ) | 182 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 19-07-2019 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Hoofd Techniek/Wetenschap/O&O | 01-11-2013 |
St. Mary's Regional Medical Center (Oklahoma)
St. Mary's Regional Medical Center (Oklahoma) Hospital/Nursing ManagementHealth Services Operates a hospital | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Health Research Association, Inc. | Corporate Officer/Principal | - |
Los Angeles County+USC Medical Center | Corporate Officer/Principal | - |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Corporate Officer/Principal | - |
Los Angeles Biomedical Research Institute at Harbor-UCLA
Los Angeles Biomedical Research Institute at Harbor-UCLA BiotechnologyHealth Technology Operates as biomedical research organization | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Bavarian Nordic A/S
Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Los Angeles Biomedical Research Institute at Harbor-UCLA
Los Angeles Biomedical Research Institute at Harbor-UCLA BiotechnologyHealth Technology Operates as biomedical research organization | Health Technology |
Health Research Association, Inc. | |
St. Mary's Regional Medical Center (Oklahoma)
St. Mary's Regional Medical Center (Oklahoma) Hospital/Nursing ManagementHealth Services Operates a hospital | Health Services |
Los Angeles County+USC Medical Center | |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Health Services |
Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau